Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengmei Yuan

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Journal of Clinical Psychopharmacology|August 14, 2018
A Pilot Study of the Effectiveness of Lithium Versus Quetiapine Immediate Release Monotherapy in Patients With Bipolar Spectrum DisordersKeming Gao, Toyomi Goto, Chengmei Yuan, et al.
Journal of Affective Disorders|July 9, 2017
Association analysis between mitogen-activated protein/extracellular signal-regulated kinase (MEK) gene polymorphisms and depressive disorder in the Han Chinese populationYingyan Hu, Wu Hong, Alicia Smith, et al.
Journal of Clinical Psychopharmacology|June 24, 2010
Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese populationYiru Fang, Chengmei Yuan, Yifeng Xu, et al.
Journal of Clinical Psychopharmacology|August 27, 2011
A pilot study of the efficacy and safety of paroxetine augmented with risperidone, valproate, buspirone, trazodone, or thyroid hormone in adult Chinese patients with treatment-resistant major depressionYiru Fang, Chengmei Yuan, Yifeng Xu, et al.
Psychopharmacology|October 12, 2013
A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depressionChen Zhang, Zezhi Li, Zhiguo Wu, et al.
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
Identification of Causal Genes and Potential Drug Targets for Restless Legs Syndrome: A Comprehensive Mendelian Randomization StudyRuiyi Qian, Xue Zhao, Dongbin Lyu, et al.
Psychiatry Research|November 25, 2010
Protective factors for posttraumatic stress disorder symptoms in a prospective study of police officersChengmei Yuan, Zhen Wang, Sabra S Inslicht, et al.
Plos One|March 24, 2017
Differential gene expression in patients with subsyndromal symptomatic depression and major depressive disorderChengqing Yang, Guoqin Hu, Zezhi Li, et al.
Neuroreport|April 9, 2014
Significantly decreased mRNA levels of BDNF and MEK1 genes in treatment-resistant depressionWu Hong, Jinbo Fan, Chengmei Yuan, et al.
BMC Psychiatry|June 7, 2014
Pharmacotherapy for acute mania and disconcordance with treatment guidelines: bipolar mania pathway survey (BIPAS) in mainland ChinaZuowei Wang, Keming Gao, Wu Hong, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Journal of Clinical Psychopharmacology|August 14, 2018
A Pilot Study of the Effectiveness of Lithium Versus Quetiapine Immediate Release Monotherapy in Patients With Bipolar Spectrum DisordersKeming Gao, Toyomi Goto, Chengmei Yuan, et al.
Journal of Affective Disorders|July 9, 2017
Association analysis between mitogen-activated protein/extracellular signal-regulated kinase (MEK) gene polymorphisms and depressive disorder in the Han Chinese populationYingyan Hu, Wu Hong, Alicia Smith, et al.
Journal of Clinical Psychopharmacology|June 24, 2010
Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese populationYiru Fang, Chengmei Yuan, Yifeng Xu, et al.
Journal of Clinical Psychopharmacology|August 27, 2011
A pilot study of the efficacy and safety of paroxetine augmented with risperidone, valproate, buspirone, trazodone, or thyroid hormone in adult Chinese patients with treatment-resistant major depressionYiru Fang, Chengmei Yuan, Yifeng Xu, et al.
Psychopharmacology|October 12, 2013
A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depressionChen Zhang, Zezhi Li, Zhiguo Wu, et al.
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
Identification of Causal Genes and Potential Drug Targets for Restless Legs Syndrome: A Comprehensive Mendelian Randomization StudyRuiyi Qian, Xue Zhao, Dongbin Lyu, et al.
Psychiatry Research|November 25, 2010
Protective factors for posttraumatic stress disorder symptoms in a prospective study of police officersChengmei Yuan, Zhen Wang, Sabra S Inslicht, et al.
Plos One|March 24, 2017
Differential gene expression in patients with subsyndromal symptomatic depression and major depressive disorderChengqing Yang, Guoqin Hu, Zezhi Li, et al.
Neuroreport|April 9, 2014
Significantly decreased mRNA levels of BDNF and MEK1 genes in treatment-resistant depressionWu Hong, Jinbo Fan, Chengmei Yuan, et al.
BMC Psychiatry|June 7, 2014
Pharmacotherapy for acute mania and disconcordance with treatment guidelines: bipolar mania pathway survey (BIPAS) in mainland ChinaZuowei Wang, Keming Gao, Wu Hong, et al.
Pageof 5